Full Year 2021 Sophia Genetics SA Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the SOPHiA GENETICS Fourth Quarter 2021 Earnings Conference Call. (Operator Instructions)
I would now like to turn the call over to your host, Jennifer Pottage, Head of Investor Relations. You may begin.
Good morning, and thank you for joining us on SOPHiA GENETICS Q4 Fiscal '21 Earnings Call. My name is Jennifer Pottage, and I am the Head of Investor Relations at SOPHiA. Joining me today are Dr. Jurgi Camblong, our Co-Founder and Chief Executive Officer; Peter Casasanto, our Chief Biopharma Officer; and Ross Muken, our Chief Financial Officer.
Before we get started, I would like to remind you that management will make statements during this call that are forward-looking within the scope of U.S. federal security laws. These statements are based on management's current views and assumptions which are subject to material risks and uncertainties that could cause actual results or events to materially differ from those projected.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |